Feb. 23, 2005 (New Orleans) — One day of high-dose oral valacyclovir treatment significantly decreases the duration of virus shedding that occurs with recurrent herpes labialis and may reduce the ...

Low-dose suppressive valacyclovir treatment of herpes zoster ophthalmicus (HZO) did not show significant benefits at 12 months but showed treatment superiority at 18 months and a reduction in the ...

Valacyclovir is a prescription drug available in oral tablet form. It is the generic version of the brand-name drug Valtrex. Doctors prescribe valacyclovir to treat infections caused by the herpes ...

HealthDay News — Patients with herpes simplex virus type 2 (HSV-2) taking high doses of antiviral therapy to control the disease continue to experience short episodes of subclinical shedding or ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — Valacyclovir can be beneficial for treating multiple episodes of keratitis or iritis in patients with ...

What long-term treatment or prevention tips do you have for herpes labialis? Do you recommend low-dose suppressive antiviral therapy? What information do you have with regard to resistance rates among ...

Anti-herpetic agents reduce recurrence of herpes simplex-2 (HSV-2) symptoms but do not completely block subclinical shedding of virus, even at high doses, researchers reported. In three complementary ...

An international team of researchers finds that taking a single daily dose of an approved antiviral drug known as valacyclovir can reduce the transmission of genital herpes to uninfected partners by ...

Reactivation of latent VZV remains a significant cause of morbidity after SCT. Twenty-five percent or more of patients undergoing SCT will experience zoster within the first year after transplant.